Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the previous year. The Net Loss for the business is ₹16.04 Crore from the profit of ₹50.80 Crore year on year. Earnings per Share is -₹0.98 for this quarter.
Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%
Tags: pharmaceuticals
Related Post
- Garden Reach Shipbuilders & Engineers Ltd Q2FY25; 10% rise in Profits
Garden Reach Shipbuilders & Engineers Ltd is a premier shipbuilding company in India under the…
-
GAIL (India) Ltd Q2FY25; 10% rise in Profits
Incorporated in 1984, GAIL, a Government of India undertaking, is an integrated natural gas company…
-
G R Infraprojects Ltd Q2FY25; 11% fall in Profits
Incorporated in the year 1995, G R Infraprojects Ltd is an integrated road Engineering, Procurement,…